Fibrocell Science Inc Price to Sales Ratio 2006-2019 | FCSC

Historical PS ratio values for Fibrocell Science Inc (FCSC) over the last 10 years. The current P/S ratio for Fibrocell Science Inc as of October 11, 2019 is .
Fibrocell Science Inc P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-10-11 2.97 1.59
2019-06-30 1.90 $1.86 1.02
2019-03-31 1.93 0 0.00
2018-12-31 1.50 0 0.00
2018-09-30 2.36 0 0.00
2018-06-30 2.71 0 0.00
2018-03-31 2.95 0 0.00
2017-12-31 3.20 0 0.00
2017-09-30 15.30 $0.01 1211.43
2017-06-30 20.05 $0.09 232.89
2017-03-31 10.00 $0.12 86.34
2016-12-31 9.45 $0.12 77.92
2016-09-30 10.80 $0.14 78.43
2016-06-30 17.25 $0.09 188.85
2016-03-31 37.50 $0.11 335.19
2015-12-31 68.25 $0.18 384.20
2015-09-30 57.75 $0.17 341.51
2015-06-30 79.05 $0.15 529.63
2015-03-31 67.65 $0.12 563.35
2014-12-31 38.85 $0.07 589.83
2014-09-30 43.50 $0.07 647.13
2014-06-30 59.85 $0.10 619.27
2014-03-31 78.45 $0.12 679.00
2013-12-31 60.90 $0.11 538.08
2013-09-30 65.70 $0.12 565.24
2013-06-30 91.80 $0.34 269.13
2013-03-31 52.50 $0.41 128.17
2012-12-31 56.25 $0.46 122.93
2012-09-30 60.00 $0.43 138.67
2012-06-30 86.25 $0.17 504.07
2012-03-31 150.00 $0.06 2395.32
2011-12-31 150.00 $3.69 40.70
2011-09-30 183.75 $8.08 22.75
2011-06-30 326.25 $12.76 25.58
2011-03-31 277.50 $17.84 15.55
2010-12-31 191.25 $19.12 10.00
2010-09-30 206.25 $16.55 12.46
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.029B $0.000B
Fibrocell Science, Inc. is an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs. Fibrocell's most advanced drug candidate, azficel-T, uses its FDA-approved proprietary autologous fibroblast technology and is in a Phase II clinical trial for the treatment of chronic dysphonia resulting from vocal cord scarring or atrophy. In collaboration with Intrexon Corporation, a leader in synthetic biology, Fibrocell is also developing gene therapies for orphan skin diseases using gene-modified autologous fibroblasts. The Company's lead orphan gene-therapy drug candidate, FCX-007, is in late stage pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Fibrocell is also in pre-clinical development of FCX-013, its second gene-therapy drug candidate, for the treatment of linear scleroderma.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.149B 13.57
Gilead Sciences (GILD) United States $80.116B 9.84
CSL (CSLLY) Australia $74.068B 0.00
Celgene (CELG) United States $70.739B 10.94
Illumina (ILMN) United States $43.832B 51.50
Vertex Pharmaceuticals (VRTX) United States $43.753B 47.28
Biogen (BIIB) United States $41.132B 7.31
Regeneron Pharmaceuticals (REGN) United States $32.769B 14.87
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.053B 11.63
Incyte (INCY) United States $16.296B 47.96
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $15.610B 0.00
Seattle Genetics (SGEN) United States $13.188B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.935B 0.00
Genmab (GNMSF) Denmark $11.848B 66.46
Exact Sciences (EXAS) United States $11.721B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.647B 51.72
Alnylam Pharmaceuticals (ALNY) United States $8.634B 0.00
Galapagos (GLPG) Belgium $8.634B 0.00
Bio-Techne Corp (TECH) United States $7.559B 52.22
Sarepta Therapeutics (SRPT) United States $6.182B 0.00
QIAGEN (QGEN) Netherlands $6.143B 20.18
ACADIA Pharmaceuticals (ACAD) United States $5.849B 0.00
Guardant Health (GH) United States $5.630B 0.00
BeiGene (BGNE) Cayman Islands $5.534B 0.00
Amarin (AMRN) Ireland $5.326B 0.00
Exelixis (EXEL) United States $5.007B 13.02
Bluebird Bio (BLUE) United States $4.936B 0.00
Horizon Therapeutics Public (HZNP) Ireland $4.911B 12.48
Moderna (MRNA) United States $4.675B 0.00
China Biologic Products (CBPO) China $4.540B 28.34
ARGENX SE-ADR (ARGX) Netherlands $4.204B 0.00
Medicines (MDCO) United States $4.154B 0.00
Repligen (RGEN) United States $3.911B 75.90
Ascendis Pharma (ASND) Denmark $3.890B 0.00
Spark Therapeutics (ONCE) United States $3.704B 0.00
Blueprint Medicines (BPMC) United States $3.533B 0.00
MorphoSys AG (MOR) Germany $3.373B 0.00
Mirati Therapeutics (MRTX) United States $2.977B 0.00
Alkermes (ALKS) Ireland $2.717B 0.00
Emergent Biosolutions (EBS) United States $2.709B 40.70
Immunomedics (IMMU) United States $2.686B 0.00
Reata Pharmaceuticals (RETA) United States $2.588B 0.00
Genomic Health (GHDX) United States $2.532B 47.48
Genmab (GMAB) Denmark $2.491B 0.00
MyoKardia (MYOK) United States $2.459B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.409B 0.00
Arena Pharmaceuticals (ARNA) United States $2.317B 4.98
Halozyme Therapeutics (HALO) United States $2.288B 0.00
RA PHARMCTL INC (RARX) United States $2.146B 0.00
Myriad Genetics (MYGN) United States $2.130B 22.36
NeoGenomics (NEO) United States $2.041B 109.17
Acceleron Pharma (XLRN) United States $2.022B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.012B 0.00
Cambrex (CBM) United States $2.005B 25.35
Ligand Pharmaceuticals (LGND) United States $1.954B 24.71
Amicus Therapeutics (FOLD) United States $1.940B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.926B 0.00
Zai Lab (ZLAB) China $1.887B 0.00
Akcea Therapeutics (AKCA) United States $1.829B 0.00
UniQure (QURE) Netherlands $1.595B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.583B 0.00
Denali Therapeutics (DNLI) United States $1.457B 0.00
Insmed (INSM) United States $1.438B 0.00
REGENXBIO (RGNX) United States $1.433B 0.00
Coherus BioSciences (CHRS) United States $1.300B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.293B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.276B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.092B 0.00
Innoviva (INVA) United States $1.081B 3.12
Zymeworks (ZYME) Canada $1.053B 0.00
Alector (ALEC) United States $1.000B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.969B 0.00
Editas Medicine (EDIT) United States $0.965B 0.00
AnaptysBio (ANAB) United States $0.942B 0.00
Sangamo Therapeutics (SGMO) United States $0.931B 0.00
Fate Therapeutics (FATE) United States $0.915B 0.00
Epizyme (EPZM) United States $0.908B 0.00
Athenex (ATNX) United States $0.872B 0.00
ANI Pharmaceuticals (ANIP) United States $0.863B 14.41
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.776B 27.45
Codexis (CDXS) United States $0.767B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Zealand Pharma (ZEAL) Denmark $0.747B 8.38
Cara Therapeutics (CARA) United States $0.745B 0.00
Twist Bioscience (TWST) United States $0.727B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.686B 0.00
Principia Biopharma (PRNB) United States $0.670B 346.75
Vanda Pharmaceuticals (VNDA) United States $0.670B 24.17
WAVE Life Sciences (WVE) Singapore $0.657B 0.00
Cytokineticsorporated (CYTK) United States $0.632B 0.00
Vericel (VCEL) United States $0.626B 0.00
Mesoblast (MESO) Australia $0.624B 0.00
Arvinas (ARVN) United States $0.589B 0.00
Heska (HSKA) United States $0.566B 73.32
MiMedx (MDXG) United States $0.564B 0.00
Intellia Therapeutics (NTLA) United States $0.531B 0.00
GENFIT S.A (GNFT) France $0.517B 0.00
Revance Therapeutics (RVNC) United States $0.514B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.509B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.502B 0.00
Retrophin (RTRX) United States $0.476B 0.00
PHARMA MAR SA (PHMMF) Spain $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.442B 0.00
Intra-Cellular Therapies (ITCI) United States $0.438B 0.00
Cellectis S.A (CLLS) France $0.419B 0.00
BioDelivery Sciences (BDSI) United States $0.418B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.407B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Stemline Therapeutics (STML) United States $0.378B 0.00
Precision BioSciences (DTIL) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Syros Pharmaceuticals (SYRS) United States $0.368B 0.00
Arcus Biosciences (RCUS) United States $0.367B 0.00
Bellus Health (BLU) Canada $0.361B 0.00
Agenus (AGEN) United States $0.358B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.358B 0.00
Kadmon Holdings (KDMN) United States $0.336B 0.00
Adverum Biotechnologies (ADVM) United States $0.333B 0.00
AC Immune SA (ACIU) Switzerland $0.326B 24.15
CytomX Therapeutics (CTMX) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.316B 0.00
Protagonist Therapeutics (PTGX) United States $0.304B 0.00
Starpharma Holdings (SPHRY) Australia $0.301B 0.00
Prothena (PRTA) Ireland $0.298B 0.00
Avid Bioservices (CDMO) United States $0.295B 0.00
Theratechnologies (THTX) Canada $0.285B 0.00
Puma Biotechnology (PBYI) United States $0.282B 0.00
PDL BioPharma (PDLI) United States $0.275B 7.09
Scholar Rock Holding (SRRK) United States $0.274B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Geron (GERN) United States $0.271B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Dynavax Technologies (DVAX) United States $0.258B 0.00
Kindred Biosciences (KIN) United States $0.245B 0.00
MannKind (MNKD) United States $0.241B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.220B 0.00
Albireo Pharma (ALBO) United States $0.217B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Inovio Pharmaceuticals (INO) United States $0.214B 0.00
OSMOTICA PHARM (OSMT) United States $0.213B 0.00
Seres Therapeutics (MCRB) United States $0.213B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.210B 0.00
Compugen (CGEN) Israel $0.207B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.77
Athersys (ATHX) United States $0.202B 0.00
Spero Therapeutics (SPRO) United States $0.198B 0.00
Sorrento Therapeutics (SRNE) United States $0.191B 0.00
ChromaDex (CDXC) United States $0.189B 0.00
Exicure (XCUR) United States $0.179B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.177B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Clovis Oncology (CLVS) United States $0.173B 0.00
Cue Biopharma (CUE) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Affimed (AFMD) Germany $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.161B 0.00
XOMA (XOMA) United States $0.158B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
Five Prime Therapeutics (FPRX) United States $0.156B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.154B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Arsanis (XFOR) United States $0.146B 0.00
Senesco Technologies (ELOX) United States $0.142B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.139B 0.00
Northwest Biotherapeutics (NWBO) United States $0.137B 0.00
Cerecor (CERC) United States $0.137B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.132B 0.00
Acorda Therapeutics (ACOR) United States $0.128B 0.00
NantKwest (NK) United States $0.125B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Strongbridge Biopharma (SBBP) United States $0.112B 4.60
Menlo Therapeutics (MNLO) United States $0.111B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.111B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Novavax (NVAX) United States $0.107B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Emmaus Life Sciences (EMMA) United States $0.100B 0.00
Celyad SA (CYAD) Belgium $0.098B 0.00
OvaScience (MLND) United States $0.094B 0.00
VBI Vaccines (VBIV) United States $0.092B 0.00
Fortress Biotech (FBIO) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.086B 0.00
Aduro Biotech (ADRO) United States $0.084B 0.00
Verastem (VSTM) United States $0.083B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Mersana Therapeutics (MRSN) United States $0.077B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.069B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Orgenesis (ORGS) United States $0.058B 21.12
Merrimack Pharmaceuticals (MACK) United States $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.053B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.051B 0.00
Arbutus Biopharma (ABUS) Canada $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Unum Therapeutics (UMRX) United States $0.045B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Ophthotech (ISEE) United States $0.042B 0.00
Evogene (EVGN) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Proteostasis Therapeutics (PTI) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.035B 0.00
Celsion (CLSN) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Clearside Biomedical (CLSD) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
BioCardia (BCDA) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
DiaMedica Therapeutics (DMAC) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00